7,376
Views
38
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Berberine regulates the Notch1/PTEN/PI3K/AKT/mTOR pathway and acts synergistically with 17-AAG and SAHA in SW480 colon cancer cells

, , , , &
Pages 21-30 | Received 03 Apr 2020, Accepted 10 Dec 2020, Published online: 08 Jan 2021

References

  • Alzamora R, O'Mahony F, Ko WH, Yip TW, Carter D, Irnaten M, Harvey BJ. 2011. Berberine reduces cAMP-induced chloride secretion in T84 human colonic carcinoma cells through inhibition of basolateral KCNQ1 channels. Front Physiol. 2:1–10.
  • Chidambara Murthy KN, Jayaprakasha GK, Patil BS. 2012. The natural alkaloid berberine targets multiple pathways to induce cell death in cultured human colon cancer cells. Eur J Pharmacol. 688(1–3):14–21.
  • Farooqi AA, Qureshi MZ, Khalid S, Attar R, Martinelli C, Sabitaliyevich UY, Nurmurzayevich SB, Taverna S, Poltronieri P, Xu BJ. 2019. Regulation of cell signaling pathways by berberine in different cancers: searching for missing pieces of an incomplete jig saw puzzle for an effective cancer therapy. Cancers. 11(4):478–494.
  • Feng Y, Cheung KF, Wang N, Liu P, Nagamatsu T, Tong Y. 2009. Chinese medicines as a resource for liver fibrosis treatment. Chin Med. 4:16–26.
  • Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H. 1999. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol. 66(2):227–233.
  • Gao XJ, Wang J, Li MQ, Wang J, Lv J, Zhang L, Sun CF, Ji JM, Yang WB, Zhao ZN, et al. 2019. Berberine attenuates XRCC1-mediated base excision repair and sensitizes breast cancer cells to the chemotherapeutic drugs. J Cell Mol Med. 23(10):6797–6804.
  • Hieronymus H, Lamb J, Ross KN, Peng XP, Clement C, Rodina A, Nieto M, Du JY, Stegmaier K, Raj SM, et al. 2006. Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell. 10(4):321–330.
  • Hsu WH, Hsieh YS, Kuo HC, Teng CY, Huang HI, Wang CJ, Yang SF, Liou YS, Kuo WH. 2007. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL. Arch Toxicol. 81(10):719–728.
  • Huang C, Liu H, Gong XL, Wu LY, Wen B. 2017. Effect of evodiamine and berberine on the interaction between DNMTs and target microRNAs during malignant transformation of the colon by TGF-β1. Oncol Rep. 37(3):1637–1645.
  • Huang C, Tao L, Wang XL, Pang Z. 2019. Berberine reversed the epithelial–mesenchymal transition of normal colonic epithelial cells induced by SW480 cells through regulating the important components in the TGF-β pathway. J Cell Physiol. 234(7):11679–11691.
  • Huang C, Wang XL, Qi FF, Pang ZL. 2019. Berberine inhibits epithelial–mesenchymal transition and promotes apoptosis of tumour-associated fibroblast-induced colonic epithelial cells through regulation of TGF-β signalling. J Cell Commun Signal. 14(1):53–66.
  • Kazaz IO, Mentese A, Demir S, Kerimoglu G, Colak F, Bodur A, Alver A, Kutlu O, Turedi S. 2020. Berberine inhibits the ischemia–reperfusion induced testicular injury through decreasing oxidative stress. Am J Emerg Med. 38(1):33–37.
  • Kim YC, Guan KL. 2015. mTOR: a pharmacologic target for autophagy regulation. J Clin Invest. 125(1):25–32.
  • Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, et al. 2006. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 313(5795):1929–1935.
  • Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J, Sun G. 2015. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol. 161:69–81.
  • Lee YR, Chen M, Pandolfi PP. 2018. The functions and regulation of the PTEN tumour suppressor: new modes and prospects. Nat Rev Mol Cell Biol. 19(9):547–562.
  • Li W, Hua B, Saud SM, Lin H, Hou W, Matter MS, Jia L, Colburn NH, Young MR. 2015. Berberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice. Mol Carcinog. 54(10):1096–1109.
  • Lin JG, Chung JG, Wu LT, Chen GW, Chang HL, Wang TF. 1999. Effects of berberine on arylamine N-acetyltransferase activity in human colon tumor cells. Am J Chin Med. 27(2):265–275.
  • Lu L, Hu JL, Wu QP, An Y, Cui W, Wang JW, Ye ZW. 2019. Berberine prevents human nucleus pulposus cells from IL-1β-induced extracellular matrix degradation and apoptosis by inhibiting the NF-κB pathway. Int J Mol Med. 43(4):1679–1686.
  • Lü Y, Han B, Yu H, Cui Z, Li Z, Wang J. 2018. Berberine regulates the microRNA-21-ITGΒ4-PDCD4 axis and inhibits colon cancer viability. Oncol Lett. 15(4):5971–5976.
  • Luongo F, Colonna F, Calapà F, Vitale S, Fiori ME, Maria RD. 2019. PTEN tumor-suppressor: the dam of stemness in cancer. Cancers. 11(8):1076–1101.
  • Lv C, Wu XT, Wang X, Su J, Zeng HW, Zhao J, Shan L, Liu RH, Li HL, Li X, et al. 2017. The gene expression profiles in response to 102 traditional Chinese medicine (TCM) components: a general template for research on TCMs. Sci Rep. 7(1):352–361.
  • Lv C, Zeng HW, Wang JX, Yuan X, Zhang C, Fang T, Yang PM, Wu T, Zhou YD, Nagle DG, et al. 2018. The antitumor natural product tanshinone IIA inhibits protein kinase C and acts synergistically with 17-AAG. Cell Death Dis. 9(2):1–13.
  • Ma XL, Chen ZJ, Wang L, Wang GS, Wang ZH, Dong XB, Wen BY, Zhang ZC. 2018. The pathogenesis of diabetes mellitus by oxidative stress and inflammation: its inhibition by berberine. Front Pharmacol. 9:782–794.
  • Mao L, Chen Q, Gong K, Xu X, Xie Y, Zhang W, Cao H, Hu T, Hong X, Zhan YY. 2018. Berberine decelerates glucose metabolism via suppression of mTOR-dependent HIF-1α protein synthesis in colon cancer cells. Oncol Rep. 39(5):2436–2442.
  • Mariadason JM. 2008. HDACs and HDAC inhibitors in colon cancer. Epigenetics. 3(1):28–37.
  • Mohammadinejad R, Ahmadi Z, Tavakol S, Ashrafizadeh M. 2019. Berberine as a potential autophagy modulator. J Cell Physiol. 234(9):14914–14926.
  • Molina DM, Jafari R, Ignatushchenko M, Seki T, Larsson EA, Dan C, Sreekumar L, Cao Y, Nordlund P. 2013. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science. 341(6141):84–87.
  • Mondal A, Bennett LL. 2016. Resveratrol enhances the efficacy of sorafenib mediated apoptosis in human breast cancer MCF7 cells through ROS, cell cycle inhibition, caspase 3 and PARP cleavage. Biomed Pharmacother. 84:1906–1914.
  • Neckers L. 2007. Heat shock protein 90: the cancer chaperone. J Biosci. 32(3):517–530.
  • Newman DJ, Cragg GM. 2016. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 79(3):629–661.
  • Park JJ, Seo SM, Kim EJ, Lee YJ, Ko YG, Ha J, Lee M. 2012. Berberine inhibits human colon cancer cell migration via AMP-activated protein kinase-mediated downregulation of integrin β1 signaling. Biochem Biophys Res Commun. 426(4):461–467.
  • Pirmoradi Z, Yadegari M, Moradi A, Khojasteh F, Mehrjerdi FZ. 2019. Effect of berberine chloride on caspase-3 dependent apoptosis and antioxidant capacity in the hippocampus of the chronic cerebral hypoperfusion rat model. Iran J Basic Med Sci. 22(2):154–159.
  • Qiao L, Wong BC. 2009. Role of Notch signaling in colorectal cancer. Carcinogenesis. 30(12):1979–1986.
  • Ruan H, Zhan YY, Hou J, Xu B, Chen B, Tian Y, Wu D, Zhao Y, Zhang Y, Chen X, et al. 2017. Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells. Oncogene. 36(50):6906–6918.
  • Sahebkar A, Watts GF. 2017. Mode of action of berberine on lipid metabolism: a new-old phytochemical with clinical applications. Curr Opin Lipidol. 28(3):282–283.
  • Schopf FH, Biebl MM, Buchner J. 2017. The HSP90 chaperone machinery. Nat Rev Mol Cell Biol. 18(6):345–360.
  • Siegel RL, Miller KD, Jemal A. 2019. Cancer statistics. CA A Cancer J Clin. 69(1):7–34.
  • Tanida I, Ueno T, Kominami E. 2008. LC3 and autophagy. Methods Mol Biol. 445:77–88.
  • Tian XH, Yang N, Li B, Zhang JP, Xu XK, Yue RC, Li HL, Chen LP, Shen YH, Zhang WD. 2016. Inhibition of HL-60 cell growth via cell cycle arrest and apoptosis induction by a cycloartane-labdane heterodimer from Pseudolarix amabilis. Org Biomol Chem. 14(9):2618–2624.
  • Wang BJ, Zheng WL, Feng NN, Wang T, Zou H, Gu JH, Yuan Y, Liu XZ, Liu ZP, Bian JC. 2018. The effects of autophagy and PI3K/AKT/m-TOR signaling pathway on the cell-cycle arrest of rats primary Sertoli cells induced by zearalenone. Toxins. 10(10):398–412.
  • Wang LH, Cao HL, Lu N, Liu LP, Wang BM, Hu TH, Israel DA, Peek RM, Polk DB, Yan F. 2013. Berberine inhibits proliferation and down-regulates epidermal growth factor receptor through activation of CBL in colon tumor cells. PLoS One. 8(2):e56666.
  • Wang LH, Liu LP, Shi Y, Cao HW, Chaturvedi R, Calcutt MW, Hu TH, Ren XB, Wilson KT, Polk DB, et al. 2012. Berberine induces caspase-independent cell death in colon tumor cells through activation of apoptosis-inducing factor. PLoS One. 7(5):e36418.
  • Wu K, Yang Q, Mu Y, Zhou L, Liu Y, Zhou Q, He B. 2012. Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin t/β-catenin signaling. Int J Oncol. 41(1):292–298.
  • Wu YY, Li TM, Zang LQ, Liu B, Wang GX. 2018. Effects of berberine on tumor growth and intestinal permeability in HCT116 tumor-bearing mice using polyamines as targets. Biomed Pharmacother. 107:1447–1453.
  • Xu LN, Lu BN, Hu MM, Xu YW, Han X, Qi Y, Peng JY. 2012. Mechanisms involved in the cytotoxic effects of berberine on human colon cancer HCT-8 cells. Biocell. 36(3):113–120.
  • Xu WS, Parmigiani RB, Marks PA. 2007. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene. 26(37):5541–5552.
  • Yao MJ, Fan XD, Yuan B, Takagi N, Liu S, Han X, Ren JG, Liu JX. 2019. Berberine inhibits NLRP3 inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell. BMC Complement Altern Med. 19:216–227.
  • Yu M, Tong X, Qi B, Qu H, Dong S, Yu B, Zhang N, Tang N, Wang L, Zhang C. 2014. Berberine enhances chemosensitivity to irinotecan in colon cancer via inhibition of NF-κB. Mol Med Rep. 9(1):249–254.
  • Zhang Y, Li B, Ji ZZ, Zheng PS. 2010. Notch1 regulates the growth of human colon cancers. Cancer. 116(22):5207–5218.
  • Zhao J, Lv C, Wu QL, Zeng HW, Guo X, Yang J, Tian SS, Zhang WD. 2019. Computational systems pharmacology reveals an antiplatelet and neuroprotective mechanism of Deng-Zhan-Xi-Xin injection in the treatment of ischemic stroke. Pharmacol Res. 147:104365–104379.